Skip to main content

Table 2 Spearman correlation analysis between clinicopathological features and AGBL2

From: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer

Clinicopathological features

AGBL2 expression (P; Spearman correlation)

Age

0.076 (0.071)

Tumor size

0.053 (0.083)

Clinical stage

0.007 (0.157)

Histological stage

0.036 (0.121)

Lymph node metastasis

0.001 (0.184)

Her2 status

0.086 (0.036)